CDRH Entrepreneurs Take Two: Streamlining Data Collection And The Path To Reimbursement

FDA’s device center launched the second round of its entrepreneurs-in-residence program, bringing in outside experts to the center to focus on streamlining data collection and the approval-to-reimbursement pathway.

Members of the second iteration of CDRH’s entrepreneurs-in-residence program met for the first time last week, hatching plans to streamline the device data-collection process and to create efficiencies in the pathway from approval to reimbursement.

As with the first go-around of the program, which started last October and wrapped up this spring, the device center has tapped members of its staff to work with outside experts to rethink some of its processes, with an eye toward facilitating innovative product development

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation